Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells
- 31 October 1995
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 55 (1), 77-84
- https://doi.org/10.1016/0960-0760(95)00156-t
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of progestagens and Org OD14 in in vitro and in vivo tumor modelsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Estrogenic and progestagenic activities coexisting in steroidal drugs: Quantitative evaluation by In vitro bioassays with human cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanismBritish Journal of Cancer, 1993
- Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditionsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Intrinsic estrogenicity of some progestagenic drugsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- A Simple and Sensitive Microtiter Plate Estrogen Bioassay Based on Stimulation of Alkaline Phosphatase in Ishikawa Cells: Estrogenic Action of Δ5Adrenal Steroids*Endocrinology, 1990
- Mechanism of the Estrogen Receptor Interaction with 4-HydroxytamoxifenMolecular Endocrinology, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptorsSteroids, 1975
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949